Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy

Journal of the Neurological Sciences

Volumn 346, Issue 1-2, 2014, Pages 75-79

  Furukawa, Takahiro ^a   Matsui, Naoko ^a   Fujita, Koji ^a   Miyashiro, Ai ^a   Nodera, Hiroyuki ^a   Izumi, Yuishin ^a   Shimizu, Fumitaka ^b   Miyamoto, Katsuichi ^c   Takahashi, Yukitoshi ^d   Kanda, Takashi ^b   Kusunoki, Susumu ^c   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Demyelination; Granulocyte colony stimulating factor; Multifocal motor neuropathy; Tumor necrosis factor

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; ANTIBODY; GANGLIOSIDE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ELECTROPHYSIOLOGY; FEMALE; HUMAN; INFLAMMATION; MALE; MOTOR NEUROPATHY; NERVE BLOCK; NEUROLOGIC DISEASE; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED MUSCLE RESPONSE; IMMUNOLOGY; MIDDLE AGED; MOTOR DYSFUNCTION; PHYSIOLOGY; POLYNEUROPATHY; RETROSPECTIVE STUDY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; CASE-CONTROL STUDIES; CYTOKINES; ELECTROMYOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOKED POTENTIALS, MOTOR; FEMALE; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; POLYNEUROPATHIES; RETROSPECTIVE STUDIES;

EID: 84911004445     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.07.059     Document Type: Article

References (40)

1. J.T. Van Asseldonk, H. Franssen, R.M. Van den Berg-Vos, J.H. Wokke, and L.H. Van den Berg Multifocal motor neuropathy Lancet Neurol 4 2005 309 319
2. J.S. Katz, G.I. Wolfe, W.W. Bryan, C.E. Jackson, A.A. Amato, and R.J. Barohn Electrophysiologic findings in multifocal motor neuropathy Neurology 48 1997 700 707
3. M. Slee, A. Selvan, and M. Donaghy Multifocal motor neuropathy: the diagnostic spectrum and response to treatment Neurology 69 2007 1680 1687
4. R. Kaji, H. Shibasaki, and J. Kimura Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy Neurology 42 1992 506 509
5. M.C. Dalakas, D.P. Stein, C. Otero, E. Sekul, E.J. Cuper, and S. McCrosky Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy Arch Neurol 51 1994 861 864
6. A. Pestronk, D.R. Cornblath, A.A. Ilyas, H. Baba, R.H. Quarles, and J.W. Griffin A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside Ann Neurol 24 1988 73 78
7. I.N. van Schaik, P.M. Bossuyt, A. Brand, and M. Vermeulen Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis Neurology 45 1995 1570 1577
8. J.S. Katz, R.J. Barohn, S. Kojan, G.I. Wolfe, S.P. Nations, and D.S. Saperstein Axonal multifocal motor neuropathy without conduction block or other features of demyelination Neurology 58 2002 615 620
9. H. Nodera, H. Bostock, Y. Izumi, K. Nakamura, R. Urushihara, and T. Sakamoto Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test Neurology 67 2006 280 287
10. A. Miyashiro, N. Matsui, Y. Shimatani, H. Nodera, Y. Izumi, and S. Kuwabara Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan Muscle Nerve 49 2014 357 361
11. J.P. Azulay, O. Blin, J. Pouget, J. Boucraut, F. Billé-Turc, and G. Carles Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study Neurology 44 1994 429 432
12. L.H. Van den Berg, H. Kerkhoff, P.L. Oey, H. Franssen, I. Mollee, and M. Vermeulen Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study J Neurol Neurosurg Psychiatry 59 1995 248 252
13. P. Federico, D.W. Zochodne, A.F. Hahn, W.F. Brown, and T.E. Feasby Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study Neurology 55 2000 1256 1262
14. M.C. Dalakas Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2004 2367 2375
15. F. Terenghi, S. Allaria, and E. Nobile-Orazio Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy J Peripher Nerv Syst 11 2006 67 71
16. K. Mizutani, N. Oka, R. Kaji, M. Matsui, K. Asanuma, and T. Kubori CD16 + CD57-natural killer cells in multifocal motor neuropathy Eur Neurol 53 2005 64 67
17. B. Perussia, G. Trinchieri, A. Jackson, N.L. Warner, J. Faust, and H. Rumpold The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies J Immunol 133 1984 180 189
18. Joint Task Force of the EFNS and the PNS European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and Peripheral Nerve Society J Peripher Nerv Syst 11 2006 1 8
19. B.R. Brooks, R.G. Miller, M. Swash, T.L. Munsat, and World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revised: revised criteria for the diagnosis of amyotrophic lateral sclerosis Amyotroph Lateral Scler Other Motor Neuron Disord 1 2000 293 299
20. T. Tateishi, R. Yamasaki, M. Tanaka, T. Matsushita, H. Kikuchi, and N. Isobe CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis J Neuroimmunol 222 2010 76 81
21. E. Nobile-Orazio, A. Cappellari, and A. Priori Multifocal motor neuropathy: current concepts and controversies Muscle Nerve 31 2005 663 680
22. A. Al-Shekhlee, R.N. Hachwi, D.C. Preston, and B. Katirji New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy Muscle Nerve 32 2005 66 72
23. E.A. Cats, W.L. van der Pol, S. Piepers, H. Franssen, B.C. Jacobs, and R.M. van den Berg-Vos Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy Neurology 75 2010 818 825
24. S. Kusunoki, A. Chiba, T. Tai, and I. Kanazawa Localization of GM1 and GD1b antigens in the human peripheral nervous system Muscle Nerve 16 1993 752 756
25. W.P. Arend, G. Palmer, and C. Gabay IL-1, IL-18, and IL-33 families of cytokines Immunol Rev 223 2008 20 38
26. A.L. Betz, G.Y. Yang, and B.L. Davidson Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain J Cereb Blood Flow Metab 15 1995 547 551
27. A. Vezzani, D. Moneta, M. Conti, C. Richichi, T. Ravizza, and A. De Luigi Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocyte overexpression in mice Proc Natl Acad Sci U S A 97 2000 11534 11539
28. R.M. Mitchell, Z. Simmons, J.L. Beard, H.E. Stephens, and J.R. Connor Plasma biomarkers associated with ALS and their relationship to iron homeostasis Muscle Nerve 42 2010 95 103
29. C. Grande, J.L. Firvida, V. Navas, and J. Casal Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma Anticancer Drugs 17 2006 1 12
30. D. Metcalf The granulocyte-macrophage colony-stimulating factors Science 229 1985 16 22
31. R. Yamasaki, M. Tanaka, M. Fukunaga, T. Tateishi, H. Kikuchi, and K. Motomura Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice J Neuroimmunol 229 2010 51 62
32. M.K. Sharief, D.A. Ingram, M. Swash, and E.J. Thompson I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome Neurology 52 1999 1833 1838
33. S. Misawa, S. Kuwabara, M. Mori, N. Kawaguchi, and T. Hattori Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy Neurology 56 2001 666 669
34. M. Roberts, H.J. Willison, A. Vincent, and J. Newsom-Davis Multifocal motor neuropathy human sera block distal motor nerve conduction in mice Ann Neurol 38 1995 111 118
35. R. Kaji, N. Oka, T. Tsuji, T. Mezaki, T. Nishio, and I. Akiguchi Pathological findings at the site of conduction block in multifocal motor neuropathy Ann Neurol 33 1993 152 158
36. D. Wallach, H. Engelmann, Y. Nophar, D. Aderka, O. Kemper, and V. Hornik Soluble and cell surface receptors for tumor necrosis factor Agents Action Suppl 35 1991 51 57
37. F. Shimizu, M. Omoto, Y. Sano, N. Matsui, A. Miyashiro, and A. Tasaki Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier J Neurol Neurosurg Psychiatry 85 2014 526 537
38. A. Caminero, M. Comabella, and X. Montalban Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revised: an ongoing story J Neuroimmunol 234 2011 1 6
39. T. Nomura, Y. Abe, H. Kamada, H. Shibata, H. Kayamuro, and M. Inoue Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice J Control Release 149 2011 8 14
40. H. Shibata, Y. Yoshioka, Y. Abe, A. Ohkawa, T. Nomura, and K. Minowa The treatment of established murine collagen-induced arthritis with a TNF1-selective antagonistic mutant TNF Biomaterials 30 2009 6638 6647